spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Cardiogenic Shock 

 HSMN NewsFeed - 23 Jul 2024
Magenta Medical Closes $105M Financing Led by Novo Holdings
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 22 Nov 2022
U.S. Food and Drug Administration Approves CSL's Hemgenix(R) eEtranacogene dezaparvovec-drlb), the First Gene Therapy for Hemophilia B
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Sep 2022
Supira Medical Announces Successful First-In-Human Use Of Its Next Generation Percutaneous Ventricular Assist Device
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Feb 2022
Supira Medical, a Shifamed Portfolio Company, Closes $30M in an Oversubscribed Series C Financing
Devices Cardiology Venture Capital
 HSMN NewsFeed - 1 Jul 2021
Windtree Appoints Diane Carman, Esq. as Senior Vice President and General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Dec 2019
Windtree Therapeutics Completes $26.4 Million Private Placement
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Mar 2018
Abiomed to Appoint New Chief Financial Officer Todd A. Trapp
Devices Cardiology Personnel
 HSMN NewsFeed - 23 Feb 2018
Getinge announces U.S. Food and Drug Administration 510(k) clearance for PulsioFlex Monitoring System and PiCCO Module
Devices Monitoring FDA
 HSMN NewsFeed - 13 Feb 2018
Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
Devices Cardiology FDA
 HSMN NewsFeed - 9 Mar 2017
New Study Finds Abiomed Impella(R) Heart Pump Reduces Injury to Kidneys During High-Risk Percutaneous Coronary Intervention
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Aug 2016
Teva Announces Launch of Generic Gleevec(R) Tablets in the United States
Biopharmaceuticals Generics Oncology Product Launch
 HSMN NewsFeed - 6 Jun 2016
Allergan Announces FDA Approval of BYVALSON(TM) (nebivolol and valsartan)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 18 Nov 2015
Spectrum Pharmaceuticals Divests Rights to ZEVALIN(R) (ibritumomab tiuxetan) in Japan and Select Other Ex-US Countries to Mundipharma
Biopharmaceuticals
 HSMN NewsFeed - 23 Sep 2015
XENiOS(R) Receives Cash Infusion from Existing Investors to Expand Commercial Operations in US and Europe
Devices Venture Capital
 HSMN NewsFeed - 6 Jan 2014
FDA Reclassifies ECP Devices for Refractory Angina as Class II
Devices Cardiology FDA
 HSMN NewsFeed - 3 Sep 2013
Spectrum Pharmaceuticals Launches Marqibo(R) (vinCRIStine sulfate LIPOSOME injection) and Ships First Commercial Orders
Biopharmaceuticals Oncology Product Launch
 HSMN NewsFeed - 14 Mar 2013
Spectrum Pharmaceuticals Gains Rights to Pivotal-Stage Captisol-Enabled(R) Melphalan
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 Jan 2013
Spectrum Pharmaceuticals Announces Promotion of Joseph Turgeon to Senior Vice President and Chief Commercial Officer as Company Builds on Recent Commercial Reorganization to Advance Growth and Market Penetration over the Next Five Years
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Aug 2012
MAQUET Cardiovascular Announces Results Of The IABP-SHOCK II Trial Of Intra-aortic Balloon Counterpulsation Therapy In Cardiogenic Shock Patients
Devices Cardiology
 HSMN NewsFeed - 2 May 2012
EKOS Corporation Announces Two More Pulmonary Embolism Clinical Studies
Devices Drug Delivery
 HSMN NewsFeed - 12 Apr 2012
Abiomed Receives CE Mark for Impella cVAD
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 5 Apr 2012
Spectrum Pharmaceuticals to Acquire Allos Therapeutics: Acquisition Expected to Be Accretive on a Cash Basis in Q4 of 2012
Biopharmaceuticals Mergers & Acquisiitons
 HSMN NewsFeed - 1 Feb 2012
FDA approves Novartis drug Gleevec(R) label recommending extending treatment to three years for certain GIST patients after surgery
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Oct 2011
MAQUET Cardiovascular Awarded Three-Year Contract From Premier Healthcare Alliance for Intra-Aortic Balloon Pumps
Devices Cardiology Group Purchasing
 HSMN NewsFeed - 21 Sep 2011
Vasomedical Announces Corporate Restructure and Appointment of New Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 19 Sep 2011
Abiomed Announces First Patient Enrolled In MINI-AMI Study
Devices Cardiology
 HSMN NewsFeed - 23 Aug 2011
Vasomedical Announces Agreement to Acquire Two China-based Companies
Devices Mergers & Acquisitions
 HSMN NewsFeed - 6 Jul 2011
Vasomedical Receives FDA 510(k) Clearance on Two Additional BIOX(TM) Monitors
Devices Monitoring Cardiology FDA
 HSMN NewsFeed - 3 May 2011
Thoratec Comments on Publication of HeartMate II(R) Bridge-to-Transplantation Post-Approval Study in JACC
Devices Cardiology
 HSMN NewsFeed - 18 Apr 2011
Baxter Announces the Acquisition of Prism Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Mar 2011
FDA Accepts for Review Spectrum Pharmaceuticals’ ZEVALIN(R) Submission for the Removal of the Bioscan
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 Mar 2011
Vasomedical Positioned to Seek Increased Reimbursement Coverage for EECP(R) Therapy
Devices Cardiology Reimbursement Personnel
 HSMN NewsFeed - 2 Dec 2010
Abiomed Receives Conditional FDA Approval for Study with Impella 2.5 in Reducing Heart Muscle Damage Following PCI in STEMI Patients
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 29 Jun 2010
Vasomedical Announces Reorganization of Its Board of Directors
Devices Cardiology Personnel
 HSMN NewsFeed - 3 Jun 2010
Study Finds Newborn Screening With Masimo SET Pulse Oximetry Increases Detection of Congenital Heart Disease
Devices Monitoring Cardiology
 HSMN NewsFeed - 9 Apr 2010
Vasomedical Announces FDA 510(k) Clearance on the First Combined ECG Holter and Ambulatory Blood Pressure Monitoring System
Devices Monitoring FDA
 HSMN NewsFeed - 31 Mar 2010
Abbott Submits Test to Aid in Identifying Patients at Risk of Developing Kidney Injury
Diagnostics FDA
 HSMN NewsFeed - 23 Feb 2010
Forest Laboratories Receives Decision from FDA for Supplemental New Drug Application for Bystolic(R)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 8 Feb 2010
Sagent Pharmaceuticals Announces FDA Approval of Labetalol Hydrochloride Injection, USP
Biopharmaceuticals Generics Cardiology FDA
 HSMN NewsFeed - 1 Feb 2010
OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Good Safety and Clinical Outcomes in Patients with Primary PCI for STEMI
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Nov 2009
ZEVALIN(R) Receives Positive Reimbursement Ruling Using Average Sales Price (ASP) Methodology
Biopharmaceuticals Oncology Reimbursement
 HSMN NewsFeed - 18 May 2009
AstraZeneca Announces TOPROL-XL(R) (Metoprolol Succinate) is Now Available
Biopharmaceuticals
 HSMN NewsFeed - 30 Mar 2009
FDA Approves Abiomed's New AB Portable Driver; Providing Patient Transport, Mobility and Ambulation without Compromising Performance
Devices FDA Cardiology
 HSMN NewsFeed - 25 Feb 2009
Life-Saving TandemHeart from CardiacAssist Has Now Been Adopted by 100 of the Nation's Elite Cardiac Centers, Including All of the Top-10 as Ranked by U.S. News & World Report
Devices Cardiology
 HSMN NewsFeed - 25 Feb 2009
Aton Pharma Acquires U.S. TIMOPTIC(R)
Biopharmaceuticals Ophthalmology Acquisitions
 HSMN NewsFeed - 5 Jan 2009
Prism Pharmaceuticals Receives FDA Approval of NEXTERONE(R) for Life-Threatening Ventricular Fibrillation and Ventricular Tachycardia
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 12 Oct 2008
TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Oct 2008
Datascope Announces New Clinical Trial of Intra-Aortic Balloon Counterpulsation in Patients With Acute Myocardial Infarction to Expand Market Utilization
Devices Cardiology
 HSMN NewsFeed - 27 Aug 2008
Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 25 Mar 2008
Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 17 Mar 2008
Abiomed Receives Conditional FDA Approval for Impella 2.5 Study for Acute Myocardial Infarction (AMI) Patients
Devices Cardiology FDA
 HSMN NewsFeed - 21 Jan 2008
Cardiome And Astellas Announce Regulatory Update
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 Dec 2007
Abiomed Announces Update on European Growth Strategy
Devices Cardiology
 HSMN NewsFeed - 21 Dec 2007
New Drug Application for Tolvaptan, Otsuka's Investigational Novel Oral Treatment for Worsening Heart Failure and Hyponatremia, Accepted by the U.S. Food and Drug Administration
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 18 Dec 2007
Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 11 Dec 2007
FDA Advisory Committee Recommends Approval of KYNAPID(TM) for Acute Atrial Fibrillation
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 3 Dec 2007
Texas Heart Institute at St. Luke's Episcopal Hospital Participates in Ground-Breaking Heart Recovery Technology Study
Devices Cardiology
 HSMN NewsFeed - 31 Oct 2007
Allergan, Inc. Receives FDA Approval for COMBIGAN(TM) (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 30 Aug 2007
Thanks to Portable Driver Available Only in Europe German Heart Institute Berlin Surpasses Highest Artificial Heart Implant Total
Devices Cardiology
 HSMN NewsFeed - 30 Aug 2007
Abiomed Receives Conditional FDA Approval for Impella 2.5 Pivotal Study at up to 150 Hospitals
Devices Cardiology
 HSMN NewsFeed - 21 Aug 2007
Internationally Renowned Artificial Organs Expert Joins HepaLife(TM)
Devices Personnel
 HSMN NewsFeed - 8 Jun 2007
Scios Announces Enrollment of First Patients in ASCEND-HF Trial in Acute Heart Failure
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 3 Jun 2007
Data Show Improved Response Rate When Zevalin Plus Rituximab Follows Short Course First-Line Treatment in Patients with Follicular Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 May 2007
Rituxan(R) Phase II Data in Patients with Relapsing-Remitting Multiple Sclerosis Presented at the American Academy of Neurology
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Apr 2007
Cardiome Announces In-Licensing Agreement With Eli Lilly and Company
Biopharmaceuticals Licensing
 HSMN NewsFeed - 20 Dec 2006
Abiomed Announces FDA 510(k) Clearance for New Intra-Aortic Balloon and Development of Integrated Console, the iPulse, for the Balloon, BVS 5000 and AB5000
Devices Cardiology FDA
 HSMN NewsFeed - 11 Dec 2006
Datascope Announces the CS300(TM) Automatic Balloon Pump and Sensation(TM) 7 Fr. Intra-Aortic Balloon Catheter
Devices Cardiology
 HSMN NewsFeed - 21 Nov 2006
Par Pharmaceutical Begins Shipment of Generic TOPROL-XL(R)
Biopharmaceuticals Generics Distribution
 HSMN NewsFeed - 13 Nov 2006
Scios Announces Selection of Independent Executive Committee and Planned Protocol Design for the ASCEND-HF Landmark International Outcomes Trial of NATRECOR(R) (nesiritide)
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 19 Oct 2006
Gleevec(R) Approved in the US for Five Rare Life-Threatening Disorders With Limited Treatment Options
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 4 Oct 2006
Schering AG and Biogen Idec Announce Start of the ZEAL Phase III Clinical Trial With Anti-Cancer Drug Zevalin(R)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Sep 2006
FDA Approves Two New Indications for Rituxan(R) in Patients With Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Sep 2006
Benefits of Vasomedical's EECP Therapy in Heart Failure Presented at the 10th Annual HFSA Scientific Meeting
Devices Cardiology
 HSMN NewsFeed - 11 Jul 2006
FDA Approves Abiomed's New Integrated Off-Pump Cannula
Devices Cardiology FDA
 HSMN NewsFeed - 27 Jun 2006
FDA Approves Abiomed's IDE for IMPELLA 5.0 Minimally Invasive Cardiac Support Systems
Devices Cardiology FDA
 HSMN NewsFeed - 22 Jun 2006
Analysis of Phase III Study Showed Rituxan(R) Plus Methotrexate Reduced Joint Damage in Rheumatoid Arthritis Patients Who Respond Inadequately to TNF Antagonist Therapies
Biopharmaceuticals
 HSMN NewsFeed - 1 Jun 2006
Scios Announces International Outcomes Trial of NATRECOR(R) (nesiritide)
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 22 May 2006
ABIOMED Announces French Regulatory Approval of the AB5000 Circulatory Support System
Devices Cardiology
 HSMN NewsFeed - 9 May 2006
Investigators Report Findings of a Phase 2 Pilot Study Evaluating Postoperative Renal Effects in Heart Failure Patients Treated with Nesiritide
Biopharmaceuticals Cardiology
Return to NewsFeed  

 Additional items found! 80

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 80 additional stories matching:
Cardiogenic Shock
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.